Nanotherapeutics receives U.S. government contract to develop oral radiation drug Oct. 4, 2011 No Comments
BioDelivery Sciences reports preliminary phase I data on BEMA-buprenorphine/naloxone Sep. 7, 2011 No Comments
PharmAthene receives Department of Defense contract for nerve agent medical countermeasure program Aug. 17, 2011 No Comments